Sporadic Alzheimer’s disease (AD) is a metabolic disease relative to impairments in brain insulin signaling and energy metabolism, which lead to increased oxidative stress, inflammation, and aggravation of insulin resistance [1]. The gene discussed is INS; the disease is Insulin resistance.